Breast cancer in patients treated for Hodgkin's disease: Clinical and pathological analysis of 76 cases in 63 patients

European Journal of Cancer

Volumn 33, Issue 14, 1997, Pages 2315-2320

  Cutuli, B ^a   Dhermain, F ^b,c,d   Borel, C ^a   De Larochefordiere, A ^c   Graic, Y ^d   De Lafontan, B ^e   Dilhyudy, J M ^f   Mignotte, H ^g   Tessier, E ^h   Tortochaux, J ⁱ   N'Guyen, T ^j   Bey, P ^k   Le Mevel Le Pourhiet, A ^l   Velten, M ^a   Arriagada, R ^b  

^a CENTRE PAUL STRAUSS   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c INSTITUT CURIE   (France)

^d CENTRE HENRI BECQUEREL   (France)

^e INSTITUT CLAUDIUS REGAUD   (France)

^f INSTITUT BERGONIÉ   (France)

^g CENTRE LÉON BÉRARD   (France)

^h CENTRE ANTOINE LACASSAGNE   (France)

ⁱ CENTRE JEAN PERRIN   (France)

^j INSTITUT JEAN GODINOT   (France)

^k CENTRE ALEXIS VAUTRIN   (France)

^l CENTRE RENÉ GAUDUCHEAU   (France)

more..

Author keywords

Breast cancer; Hodgkin's disease; Radiation therapy; Second malignancies; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; TAMOXIFEN; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; SECOND CANCER; TREATMENT OUTCOME;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031405592     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00235-9     Document Type: Article

References (37)

1. Levitt SH, Lee CKK, Aeppli D, Lindgren B, Peterson BA. The role of radiation therapy in Hodgkin's disease: experience and controversy. Cancer. 70:1992;693-703.
2. Henry-Amar M. Second cancer after the treatment for Hogkin's disease: A report from the International Database on Hodgkin's disease. Ann Oncol. 3:(Suppl. 4):1992;S117-S128.
3. Boice JD. Second cancer after Hodgkin's disease: The price of success? J Natl Cancer Inst. 85:1993;4-5.
4. Rubin P, Zagars G, Chuang C, Thomas EM. Hodgkin's disease: is there a price for successful treatment? A 25-year experience. Int J Radiat Oncol Biol Phys. 12:1986;153-166.
5. Abrahamsen JF, Andersen A, Hannisdal E, et al. Second malignancies after treatment of Hodgkin's disease: The influence of treatment, follow-up time, and age. J Clin Oncol 1993, 11, 255-261.
6. Boivin JF. Second cancer and other late side effects of cancer treatment. A review. Cancer. 65:1990;770-775.
7. Cimino G, Papa G, Tura S, et al. Second primary cancer following Hodgkin's disease: Updated results of an Italian multicentric study. J Clin Oncol 1991, 9, 432-437.
8. Cosset JM, Henry-Amar M, et al. Les tumeurs solides secondaires après irradiation pour maladie de Hodgkin: l'expérience de l'lnstitut Gustave Roussy. Bull Cancer 1992, 79, 387-388.
9. Rodriguez MA, Fuller LM, Zimmermann SO, et al. Hodgkin's disease: study of treatment intensities and incidences of second malignancies. Ann Oncol 1993, 4, 125-131.
10. Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst. 85:1993;25-31.
11. Yahalom J, Petrek JA, Biddinger PW, et al. Breast cancer in patients irradiated for Hodgkin's disease: A clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol 1992, 10, 1674-1681.
12. Van Leeuwen FE, Klokman WJ, Hageenbeek A, et al. Second cancer risk following Hodgkin's disease: a 20 years follow-up study. J Clin Oncol 1994, 12, 312-325.
13. Bathia S, Robison LL, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996, 334, 745-751.
14. Sankila R, Garwicz S, Olser JH, et al. Risk of subsequent malignant neoplasm among 1641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five nordic countries. J Clin Oncol 1996, 14, 1442-1446.
15. Aisenberg AC, Finkelstein DM, Doppke KP, Boivin JF, Willet CG. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer. 79:1997;1203-1210.
16. Boivin JF, Hutchison GB, Zauber AG, et al. Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 1995, 87, 732-741.
17. Anderson N, Lokich J. Bilateral breast cancer after cured Hodgkin's disease. Cancer. 65:1990;221-223.
18. Carey RW, Linggood RM, Wood W, Blitzer PH. Breast cancer developing in four women cured of Hodgkin's disease. Cancer. 54:1984;2234-2236.
19. Colvett KT. Bilateral breast carcinoma after radiation therapy for Hodgkin's disease. South Med J. 88:1995;239-242.
20. Cook KL, Adler DD, Lichter AS, Ideda DM, Helvie MA. Breast carcinoma in young women previously treated for Hodgkin's disease. Am J Roentgenol. 155:1990;39-42.
21. Dershaw DD, Yahalom J, Petrek JA. Breast carcinoma in women previously treated for Hodgkin disease: mammographic evaluation. Radiology. 184:1992;421-423.
22. Janjan NA, Wilson JF, Gillin M, et al. Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease. Cancer 1988, 61, 252-254.
23. Kaldor JM, Lasset C. Second malignancies following Hodgkin's disease. In Somers R, Henry-Amar M, Meerwaldt JK, Carde P. eds. Treatment Strategy in Hodgkin's Disease. Montrouge, John Libbey-Eurotext Ltd, 1990, 196, 139-150.
24. De La Rochefordiere A, Asselain B, Scholl S, et al. Simultaneous breast carcinomas: A retrospective review of 149 cases. Int J Radiat Oncol Biol Phys 1994, 30, 35-41.
25. Roubidoux MA, Helvie MA, Lai NE, Paramagul C. Bilateral breast cancer: Early detection with mammography. Radiology. 196:1995;427-431.
26. Schraub S, Mercier M, Bourgeois P. Cancers multiples. Encycl Med Chir Ed Techniques. J0031:(A50):1991;1-12.
27. Land CE. Low-dose radiation. A cause of breast cancer? Cancer. 46:1980;868-873.
28. Land CE, Boice JD Jr, Shore RE, Norman JE, Tokunaga M. Breast cancer risk from low-dose exposures to ionizing radiation: Results of parallel analysis of three exposed populations of women. J Natl Cancer Inst. 65:1980;353-376.
29. Levitt SH, Mandel JS. Breast carcinogenesis: risk of radiation. Int J Radiat Oncol Biol Phys. 11:1985;1421-1423.
30. Miller RW, Van De Geijn J, Raubitschek AA, Orr K, Odunieff P, Glatstein E. Dosimetric considerations in treating mediastinal disease with mantle fields: characterization of the dose under mantle blocks. Int J Radiat Oncol Biol Phys. 32:1995;1083-1095.
31. Zellmer DL, Wilson JF, Janjan NA. Dosimetry of the breast for determining carcinogenic risk in mantle irradiation. Int J Oncol Biol Phys. 21:1991;1343-1351.
32. Cutuli BF. Cancer du sein après maladie de Hodgkin. J Gynecol Obstet Biol Reprod. 25:1996;301-302.
33. Travis LB, Curtis RE, Boice JD. Late effects of treatment for childhood Hodgkin's disease (replay). N Engl J Med. 335:1996;352-353.
34. Donaldson SS. Hodgkin's disease in children. Semin Oncol. 17:1990;736-748.
35. Donaldson SS, Hancock SL. Late effects of treatment for childhood Hodgkin's disease (replay). N Engl J Med. 335:1996;354-355.
36. Swerdlow AJ, Douglas AJ, Hudson Vaughan G, Hudson Vaughan B, Bennett MH, MacLennan KA. Risk of second primary cancer after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British national lymphoma investigation. Br Med J. 304:1992;1137-1143.
37. Tucker M, Coleman C, Cox R, Varghese A, Rosenberg SA. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med. 318:1988;76-81.